Earnings‑Driven Upgrades

Progyny’s recent earnings trajectory has generated a cascade of analyst upgrades, valuation shifts, and momentum signals that are reshaping the stock’s outlook. The company’s current‑fiscal‑year EPS is projected at $2.04 on $1.38 in revenue, a 7.94 % increase in EPS and 7.01 % rise in revenue versus the prior year. For the next fiscal year, the consensus expects $2.31 in EPS on $1.49 in revenue. Analysts across the board have raised their estimates for both the coming quarter and the full year, with a 7.14 % uptick in the forward 12‑month Zacks Consensus EPS in the past 30 days. The most recent quarter’s adjusted EPS exceeded consensus, yet the company’s 2026 guidance missed analyst forecasts for both revenue and adjusted EPS, flagging potential concerns about sustaining momentum.